FDA approves new over-the-counter pain reliever that combines Tylenol and Naproxen

The FDA approved a new over-the-counter pain reliever combining acetaminophen (Tylenol) and naproxen (Aleve) into a single tablet, offering up to 12 hours of relief for common conditions like headaches and back pain. The medication provides faster and longer-lasting relief than either drug alone but carries risks such as liver damage from acetaminophen and NSAID-related complications from naproxen. Doctors advise careful label reading to avoid overdosing and recommend consulting healthcare providers for those with certain health conditions.